Cargando…

Clozapine and COVID-19

Detalles Bibliográficos
Autores principales:	Silva, Edward, Gee, Siobhan, Smith, Shubulade, Gaughran, Fiona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058871/ https://www.ncbi.nlm.nih.gov/pubmed/32718376 http://dx.doi.org/10.1192/bjb.2020.66

Ejemplares similares

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

The disquietude of clozapine continuation during the COVID‐19 pandemic
por: Shoib, Sheikh, et al.
Publicado: (2022)

The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2020)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2021)

Authors' reply — Clozapine for mitochondrial psychosis
por: Demily, Caroline, et al.
Publicado: (2017)

Maintenance doses for clozapine: past and present
por: Sharma, Avneet
Publicado: (2018)

Clozapine prescribing in COVID-19 positive medical inpatients: a case series
por: Butler, Matthew, et al.
Publicado: (2020)

Inflammatory response to clozapine in the absence of myocarditis: case report
por: Davey, Patrick, et al.
Publicado: (2016)

RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Gupta, Sumeet, et al.
Publicado: (2023)

Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382–3
por: Eagleton, Marie, et al.
Publicado: (2021)

Author's Reply. RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Kitchen, David
Publicado: (2023)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Reasons for admission to a general medical hospital for patients taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2022)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

Low dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation
por: Demily, Caroline, et al.
Publicado: (2016)

Clozapine in the Time of COVID-19
por: Boland, Xavier, et al.
Publicado: (2020)

Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis
por: Harrison, Rebecca N.S., et al.
Publicado: (2016)

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial
por: Lally, John, et al.
Publicado: (2018)

Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team
por: Gee, Siobhan, et al.
Publicado: (2021)

Clozapine Toxicity in the Setting of COVID-19
por: Dotson, Samuel, et al.
Publicado: (2020)

Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment
por: Gee, Siobhan, et al.
Publicado: (2015)

Clozapine treatment and risk of COVID-19
por: Osimo, Emanuele F., et al.
Publicado: (2022)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

The assertive approach to clozapine: nasogastric administration
por: Till, Alex, et al.
Publicado: (2019)

Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)

Clozapine: COVID-19 infection: case report
Publicado: (2020)

Clozapine prescribing and safety during COVID-19
por: Wadoo, Ovais, et al.
Publicado: (2021)

Clozapine treatment during the COVID-19 pandemic
por: Dąbrowska, E., et al.
Publicado: (2021)

Ritonavir and COVID-19: pragmatic guidance is important
por: Waters, Laura, et al.
Publicado: (2022)

Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology
por: Martland, Rebecca, et al.
Publicado: (2023)

Obesity and its implications for COVID-19 pandemic in South Africa
por: van Vollenstee, Fiona A., et al.
Publicado: (2021)

An interactive tracker for ceasefires in the time of COVID-19
por: Allison, John, et al.
Publicado: (2021)

Recovery after critical illness in COVID-19 ICU survivors
por: Parker, Alexander J., et al.
Publicado: (2021)

COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report
por: Chengappa, K.N. Roy, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Clozapine treatment and risk of severe COVID‐19 infection
por: Ohlis, Anna, et al.
Publicado: (2021)

Elevated clozapine levels in patients with COVID-19 infection
por: Bonany, J. Marti, et al.
Publicado: (2021)

Brazil's COVID-19 response
por: da Silva Bastos, Maria Helena
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngt40eo7oak793hl6qc6a2l3lk